Katherine Tarlock

8PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHaematological tumoursAdolescent healthInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2025
A Case of Blinatumomab Efficacy in RAM Immunophenotype/CBFA2T3::GLIS2 Fusion AML.

Maya Ball-Burack, Andrew Menssen, Lisa Eidenschink Brodersen

|Apr 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Benjamin J Huang, Lauren K Meyer, Todd A Alonzo

|Jan 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.

Katherine Tarlock, Robert B Gerbing, Rhonda E Ries

|Sep 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Katherine Tarlock, Xiaowei Liu, Charles G Minard

|Mar 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.

Jessica A Pollard, Todd A Alonzo, Robert Gerbing

|Aug 22, 2021
Targeted Therapy in Pediatric AML: An Evolving Landscape.

LaQuita M Jones, Katherine Tarlock, Todd Cooper

Pageof 2

Frequent Collaborators

4 joint publications

Todd M Cooper

4 joint publications

Alan S Gamis

3 joint publications

Richard Aplenc

2 joint publications

Benjamin J Huang